1. Bergdoll, M.S. and A.C.L. Wong Staphylococcal intoxications. In foodborne Infections and Intoxications 3e. Chapter 14, (2006) Elsevier, Inc.
  2. Bergdoll, M.S. Enterotoxins. In Staphylococci and Staphylococcal Infections, 2. (1983) Academic Press, London. (SEA-E)
  3. Freed, R.C., M.L. Evenson, R.F. Reiser & M.S. Bergdoll. Enzyme-Linked Immunosorbent Assay for Detection of Staphylococcal Enterotoxins in Foods (1982) Appl. Environ. Microbiol. 44:1349-55.
  4. Bergdoll, M.S. et al. A New Staphylococcal Enterotoxin, Enterotoxin F, Associated with Toxic-Shock-Syndrome Staphylococcus Aureus Isolates. (1981) Lancet. 1017-21.
  5. Munson, S.H. et al. Identification and Characterization of Staphylococcal Enterotoxin Types G and I from Staphylococcus aureus. (1998) Infection and Immunity. 66:3337-48.
  6. Su, Y.-C. and A.C.L. Wong. Identification and Purification of a New Staphylococcal Enterotoxin, H. (1995) Appl. Environ. Microbiol. 61:1438-43
  7. Zhang, S. et al. The Enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (SEJ). (1998) FEMS Microbiol. Lett. 168(2):227-33.
  8. Owen, P.M. et al. Biochemical and Biological Properties of Staphylococcal Enterotoxin K. (2001) Infection & Immunity. 69:360-366.
  9. SEL, Dr. Pat Schlieverts Group (unpublished)
  10. Jarraud, S. et al. egc, A Highly Preventive Operon of Enterotoxin Gene, Forms a Putative Nursery of Superantigens in Staphylococcus aureus. 2001. J. Immunology. 166:669-677. An Erratum to this article was published in J. Immunology 166:4259. (SEM, N & O).
  11. Reiser, R.F. et al. Purification and Some Physicochemical Properties of Toxic-Shock-Toxin. (1983) Biochemistry. 22:3907-12. (TSST-1).
  12. Reiser, R.F. et al. Production of Toxic Shock Syndrome Toxin-1 by Staphylococcus aureus. Restricted to Endogenous Air in Tampons. (1987) J. Clin. Microbiol. 25:1450-52.
  13. Schlievert, P.M. et al. Identification and Characterization of an Exotoxin from Staphylococcus aureus associated with Toxic-Shock Syndrome. (1981) Infect. Dis. 143:509-516. [This is the first reference to Pyrogenic Exotoxin C. (PEC, aka SEF & TSST-1)]
  14. Schlievert, P.M. & J.A. Kelly. Staphylococcal Pyrogenic Exotoxin C: Further Characterization. (1982) Ann. Intern. Med. 96(6 pt. 2):982-986.
  1. Taranta, A. Lymphocyte Mitogens of Staphylococcal Origin. (1974) Ann. N.Y. Acad. Sci. >strong>236:362-375
  2. White, J. et al. The VB-Specific Superantigen Enterotoxin B: Stimulation of Mature T Cells and Clonal Deletion in Neonatal Mice. (1989) Cell. 56:27-35. (Note: This is the 1st paper to use the term Superantigen!)
  3. Marrack, P. & J. Kappler. The Staphylococcal Enterotoxins and Their Relatives. (1990) Science. 248:705-711.
  4. Johnson H. et al. Superantigens in Human Disease. (1992) Scientific American. April:92-101.
  5. Hudson, K.R. et al. Two adjacent Residues in Staphylococcal Enterotoxins A and E Determine T Cell Receptor VB Specificity. (1993) J. Exp. Med. 177:175-184
  6. Kotb, M. Bacterial Pyrogenic Exotoxins as Superantigens. (1995) Clin. Microbiol. Rev. 8:411-426
  7. Proft, T. & J. Fraser. Superantigens: Just Like Peptides Only Different. (1998) J. Clin. Immunol. Bernal, A. et al. 19:149-157
  8. Al-Daccak, R. et al. Staphylococcal Enterotoxin D is a Promiscuous Superantigen Offering Multiple Modes of Interactions with the MHC Class II Receptors. (1998) J. Immunology. 160:225-232.
  9. Jarraud, S. et al. egc, A Highly Prevalent of Enterotoxin Gene, Forms a Putative Nursery of Superantigens in Staphylococcus aureus. (2001) J. Immunology. 166:669-677
  10. LeClaire, R.D. ans S. Bavari. Human Antibodies to Bacterial Superantigens and Their Ability to Inhibit T-Cell Activation and Lethality. (2001) Antimicrobial Agents and Chemotherapy. 45:460-463

Pless, D.D., E.R. Torres, E.K. Reinke, S. Bavari.High-Affinity, Protective Antibodies to the Binding Domain of Botulinum Neurotoxin Type A. (2001) Infect Immunity.69(1): 570-574.

  1. Imanishi, K. et al. Activation of Murine T-Cells by Streptococcal Pyrogenic Exotoxin Type A. Requirementfor MHC Class II Molecules on Accessory Cells and Identification of VB Elements in T-Cell Receptor of Toxin-reactive T-Cells. (1990) J. Immunol. 145:3170-3176.
  2. Li, P-L. et al. The Superantigen Streptococcal Pyrogenic Exotoxin C (SPE-C) Exhibits a Novel Mode of Action. (1997) J. Exp. Med. 186:375-383.
  3. McCormick, J.K. et al. Functional Characterization of Streptococcal Pyrogenic Exotoxin J, a Novel Superantigen. (2001) Infection and Immunity 69:1381-1388.
  1. Strockbine, N.A. et al. Characterization of Monoclonal Antibodies against Siga-Like Toxin from Escherichia coli. (1985) Infection and Immunity. 50:695-700
  2. Pouch Downes, F. et al. Affinity Purification and Characterization of Shiga-Like Toxin II and Production of toxin-specific Monoclonal Antibodies. Infection and Immunity. 56:1926-1933.
  3. Perera, L.P. et al. Isolation and Characterization of Monoclonal Antibodies to Shiga-Like Toxin II of Enterohemorrhagic Escherichia coli and use of Monoclonal Antibodies in a Colony Enzyme-Linked Immunosorbent Assay (1998) J. Clin Microbiol. 26:2127-213
  4. Padhye, V.V. et al. Production and Characterization of Monoclonal Antibodies to Verotoxins 1 and 2 from Escherichia coli of Serotype O 157:H7. (1989) J. Med. Micro. 30:219-226
  1. Christopher, G.W., et al. Biological Warfare - A Historical Perspective. (1997). JAMA. 278:412-417
  2. Franz, D.R., et al. Clinical Recognition and Management of Patients Exposed to Biological Agents.
    (1997) JAMA. 278:399-411
  3. Schmitt, C.K. et al. Bacterial Toxins: Friends or Foes? (1999). Emerging Infectious Diseases. 5:224-234